Literature DB >> 20526332

Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits.

Heike Tost1, Dieter F Braus, Shabnam Hakimi, Matthias Ruf, Christian Vollmert, Fabian Hohn, Andreas Meyer-Lindenberg.   

Abstract

Structural remodeling has been observed in the human brain over periods of weeks to months, but the molecular mechanisms governing this process remain incompletely characterized. Using multimodal pharmaco-neuroimaging, we found that acute D2 receptor blockade induced reversible striatal volume changes and structural-functional decoupling in motor circuits within hours; these alterations predicted acute extrapyramidal motor symptoms with high precision. Our findings suggest a role for D2 receptors in short-term neural plasticity and identify a potential biomarker for neuroleptic side effects in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20526332     DOI: 10.1038/nn.2572

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  15 in total

1.  Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service.

Authors:  J Kamin; S Manwani; D Hughes
Journal:  Psychiatr Serv       Date:  2000-03       Impact factor: 3.084

Review 2.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

Authors:  G E Alexander; M D Crutcher; M R DeLong
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

3.  The role of dopamine receptors in regulating the size of axonal arbors.

Authors:  C L Parish; D I Finkelstein; J Drago; E Borrelli; M K Horne
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 4.  Brain imaging research: does the science serve clinical practice?

Authors:  Dean F Wong; Gerhard Gründer; James Robert Brasic
Journal:  Int Rev Psychiatry       Date:  2007-10

5.  Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery.

Authors:  Anne-Noël Samaha; Greg E Reckless; Philip Seeman; Mustansir Diwan; José N Nobrega; Shitij Kapur
Journal:  Biol Psychiatry       Date:  2008-03-04       Impact factor: 13.382

6.  Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.

Authors:  Giorgio Marchese; Maria Antonietta Casu; Francesco Bartholini; Stefania Ruiu; Pierluigi Saba; Gian Luigi Gessa; Luca Pani
Journal:  Eur J Neurosci       Date:  2002-04       Impact factor: 3.386

7.  Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size.

Authors:  C L Parish; D Stanic; J Drago; E Borrelli; D I Finkelstein; M K Horne
Journal:  Eur J Neurosci       Date:  2002-09       Impact factor: 3.386

8.  D2 antidopaminergic modulation of frontal lobe function in healthy human subjects.

Authors:  Heike Tost; Andreas Meyer-Lindenberg; Sabine Klein; Andrea Schmitt; Fabian Höhn; Amrei Tenckhoff; Matthias Ruf; Gabriele Ende; Marcella Rietschel; Fritz A Henn; Dieter F Braus
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

9.  Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition.

Authors:  Andreas Meyer-Lindenberg; Richard E Straub; Barbara K Lipska; Beth A Verchinski; Terry Goldberg; Joseph H Callicott; Michael F Egan; Stephen S Huffaker; Venkata S Mattay; Bhaskar Kolachana; Joel E Kleinman; Daniel R Weinberger
Journal:  J Clin Invest       Date:  2007-02-08       Impact factor: 14.808

10.  Changes in gray matter induced by learning--revisited.

Authors:  Joenna Driemeyer; Janina Boyke; Christian Gaser; Christian Büchel; Arne May
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

View more
  46 in total

1.  General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance.

Authors:  Alex Fornito; Jong Yoon; Andrew Zalesky; Edward T Bullmore; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

2.  Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density.

Authors:  Paolo Fusar-Poli; Andreas Meyer-Lindenberg
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

Review 3.  [Frontal brain volume reduction due to antipsychotic drugs?].

Authors:  V Aderhold; S Weinmann; C Hägele; A Heinz
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

4.  The relationship between regional and inter-regional functional connectivity deficits in schizophrenia.

Authors:  Andrew Zalesky; Alex Fornito; Gary F Egan; Christos Pantelis; Edward T Bullmore
Journal:  Hum Brain Mapp       Date:  2011-09-16       Impact factor: 5.038

5.  Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: a longitudinal study.

Authors:  M Mallar Chakravarty; Judith L Rapoport; Jay N Giedd; Armin Raznahan; Philip Shaw; D Louis Collins; Jason P Lerch; Nitin Gogtay
Journal:  Hum Brain Mapp       Date:  2014-12-11       Impact factor: 5.038

6.  Haloperidol and delirium in the ICU: the finger pointing to the moon.

Authors:  Nicola Latronico
Journal:  Intensive Care Med       Date:  2018-06-23       Impact factor: 17.440

7.  A splitting brain: Imbalanced neural networks in schizophrenia.

Authors:  Mingli Li; Wei Deng; Zongling He; Qiang Wang; Chaohua Huang; Lijun Jiang; Qiyong Gong; Doug M Ziedonis; Jean A King; Xiaohong Ma; Nanyin Zhang; Tao Li
Journal:  Psychiatry Res       Date:  2015-03-11       Impact factor: 3.222

Review 8.  Antipsychotic drug effects in schizophrenia: a review of longitudinal FMRI investigations and neural interpretations.

Authors:  C C Abbott; A Jaramillo; C E Wilcox; D A Hamilton
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

9.  The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder.

Authors:  Chadi G Abdallah; Andrea Jackowski; Ramiro Salas; Swapnil Gupta; João R Sato; Xiangling Mao; Jeremy D Coplan; Dikoma C Shungu; Sanjay J Mathew
Journal:  Neuropsychopharmacology       Date:  2017-03-08       Impact factor: 7.853

10.  Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication.

Authors:  Nathan L Hutcheson; David G Clark; Mark S Bolding; David M White; Adrienne C Lahti
Journal:  Psychiatry Res       Date:  2013-10-22       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.